{{Rsnum
|rsid=11957313
|Gene=KCNIP1
|Chromosome=5
|position=170523390
|Orientation=plus
|GMAF=0.1983
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=KCNIP1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 1.8 | 22.1 | 76.1
| HCB | 5.1 | 35.8 | 59.1
| JPT | 6.2 | 28.3 | 65.5
| YRI | 10.2 | 46.3 | 43.5
| ASW | 3.5 | 43.9 | 52.6
| CHB | 5.1 | 35.8 | 59.1
| CHD | 6.4 | 41.3 | 52.3
| GIH | 3.0 | 22.0 | 75.0
| LWK | 14.5 | 44.5 | 40.9
| MEX | 1.7 | 19.0 | 79.3
| MKK | 6.4 | 30.8 | 62.8
| TSI | 3.9 | 17.6 | 78.4
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19010793
|Trait=Normalized brain volume
|Title=Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
|RiskAllele=
|Pval=0.000009
|OR=NR
|ORtxt=NR
}}

{{PharmGKB
|RSID=rs11957313
|Name_s=
|Gene_s=KCNIP1
|Feature=
|Evidence=PubMed ID:19010793; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. (Initial Sample Size: 753 cases, 883 controls; Replication Sample Size: NR); (Region: 5q35.1; Reported Gene(s): KCNIP1; Risk Allele: rs11957313-?); (p-value= 0.000009).This variant is associated with Normalized brain volume.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740741
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs11957313
|overall_frequency_n=26
|overall_frequency_d=128
|overall_frequency=0.203125
|n_genomes=19
|n_genomes_annotated=0
|n_haplomes=22
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}